KDR and neoplasm: Further studies have found that NRP1 can still promote tumour angiogenesis, accelerate the growth and proliferation of tumour cells, and inhibit the apoptosis of tumour cells in the absence of VEGFR14; this may indicate that NRP1 can form co-receptors with some non-VEGFR growth factor receptors15,16.